ENTITY
CanSino Biologics

CanSino Biologics (688185 CH)

90
Analysis
Health CareChina
CanSino Biologics Inc. develops and manufactures biological vaccine products. The Company discovers quadrivalence meningococcal conjugate, pneumococcal polysaccharide, and adenovirus vector-based tuberculosis vaccines for human use. CanSino Biologics serves customers worldwide.
more
Refresh
Filing Icon
No filings found
We’ll display filings we find for CanSino Biologics here
x